ACT - アカシア・リサ―チ (AdvisorShares Vice ETF) アカシア・リサ―チ

 ACTのチャート


 ACTの企業情報

symbol ACT
会社名 Acacia Research Corp (アカシア・リサ―チ)
分野(sector)   
産業(industry)   
業種    金融(Financials)
概要 事業概要 --   アカシア・リサ―チは米国の特許取得・ライセンス企業。主に特許権の取得、ライセンス供与・維持・管理に従事する。特許者の特許出願、保護、ライセンス供与、訴訟を支援。また、経営不振企業やベンチャ―企業とパ―トナ―となり、特許を取得するほか、米国内外の特許権を買い取る。181件の特許権を所有、管理する。本社はカリフォルニア州。   
本社所在地 520 Newport Center Drive 12th Floor Newport Beach CA 92660 USA
代表者氏名
代表者役職名
電話番号
設立年月日 33970
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 13人
url www.acaciaresearch.com
nasdaq_url https://www.nasdaq.com/symbol/act
adr_tso
EBITDA EBITDA ー
終値(lastsale) 27.0698
時価総額(marketcap) 14888390
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 ACTのテクニカル分析


 ACTのニュース

   Buccal Drug Delivery System Market Year: 2020-2027 Forecasts and its Details Analysis by Actavis, Applied Pharma Research, Ardea Biosciences, BioDelivery Sciences, Cynapsus  2020/10/15 13:03:09 OpenPR
A report by The Insight Partner's on the Buccal Drug Delivery System Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics
   Allergic Conjunctivitis Drugs Market (COVID-19 Impact Analysis), 2020 Top Impacting Factors That Could Escalate Markets Growth | Akron pharmaceuticals, Lupin Limited, Actavis Plc, Allergan, Novartis AG, Pfizer  2020/10/12 14:28:51 OpenPR
The ALLERGIC CONJUNCTIVITIS DRUGS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution
   Takeda, Teva must face reverse payment claims over ADHD drug  2020/10/09 21:49:07 Reuters
Takeda Pharmaceutical and Teva Pharmaceutical Industries must face claims that their predecessors Shire Plc and Actavis delayed launch of a generic version of Shire's ADHD drug Intuniv with illegal patent settlements.
   2020-2025: Stress Management Drug Market Evolving Opportunities & Advancement with Top Key Players: Actavis Generics, Sanofi, Janssen, Pfizer, Intra-Cellular Therapies, Alkermes, Otsuka  2020/10/07 11:28:53 OpenPR
Global Stress Management Drug Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players in the market. This research report offers granulated yet in-depth analysis of revenue share, market segments, revenue
   Fibromyalgia Drugs Market Capacity, Production, Revenue, Price and Gross Margin, Industry Analysis & Forecast by 2026| Pfizer, Eli Lilly, Actavis  2020/10/02 06:19:12 OpenPR
Fibromyalgia Drugs Market is expected to grow significantly over next few years and generate considerable market for Fibromyalgia Drugs. Market Report Expert has recently published a research report titled, “ Fibromyalgia Drugs Market Outlook and Statistics, 2020-2026". The report has been
   Buccal Drug Delivery System Market Year: 2020-2027 Forecasts and its Details Analysis by Actavis, Applied Pharma Research, Ardea Biosciences, BioDelivery Sciences, Cynapsus  2020/10/15 13:03:09 OpenPR
A report by The Insight Partner's on the Buccal Drug Delivery System Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics
   Allergic Conjunctivitis Drugs Market (COVID-19 Impact Analysis), 2020 Top Impacting Factors That Could Escalate Markets Growth | Akron pharmaceuticals, Lupin Limited, Actavis Plc, Allergan, Novartis AG, Pfizer  2020/10/12 14:28:51 OpenPR
The ALLERGIC CONJUNCTIVITIS DRUGS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis taking into account major factors such as revenue, cost, and gross margin. The report is sure to offer brilliant solution
   Takeda, Teva must face reverse payment claims over ADHD drug  2020/10/09 21:49:07 Reuters
Takeda Pharmaceutical and Teva Pharmaceutical Industries must face claims that their predecessors Shire Plc and Actavis delayed launch of a generic version of Shire's ADHD drug Intuniv with illegal patent settlements.
   2020-2025: Stress Management Drug Market Evolving Opportunities & Advancement with Top Key Players: Actavis Generics, Sanofi, Janssen, Pfizer, Intra-Cellular Therapies, Alkermes, Otsuka  2020/10/07 11:28:53 OpenPR
Global Stress Management Drug Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players in the market. This research report offers granulated yet in-depth analysis of revenue share, market segments, revenue
   Fibromyalgia Drugs Market Capacity, Production, Revenue, Price and Gross Margin, Industry Analysis & Forecast by 2026| Pfizer, Eli Lilly, Actavis  2020/10/02 06:19:12 OpenPR
Fibromyalgia Drugs Market is expected to grow significantly over next few years and generate considerable market for Fibromyalgia Drugs. Market Report Expert has recently published a research report titled, “ Fibromyalgia Drugs Market Outlook and Statistics, 2020-2026". The report has been
   Teva to pay $20 mln to settle Intuniv pay-for-delay claims  2020/09/02 21:34:48 Reuters
Teva Pharmaceutical Industries has agreed to pay $20 million to settle claims by direct purchasers of Shire's ADHD drug Intuniv to settle claims that Teva's predecessor, Actavis, and Shire delayed launch of a generic version of the drug with an illegal patent lawsuit settlement.
   Former Actavis Head Of M&A Joins Psychedelics Company As CEO  2020/08/31 20:14:25 Investing News Network
Drysdale will serve as CEO, bringing to the table more than 3 decades of experience in the health care sector. The post Former Actavis Head Of M&A Joins Psychedelics Company As CEO appeared first on Investing News Network .
   FDA OKs Teva's generic pemetrexed for lung cancer (NYSE:TEVA)  2020/08/24 20:00:06 Seeking Alpha
The FDA approves Teva Pharmaceutical Industries (TEVA -2.6%) units Actavis' generic pemetrexed for the treatment of locally advanced or metastatic non-squa
   AdvisorShares Vice ETF: Sin Stocks With A Unique Angle (NASDAQ:ACT)  2020/08/18 12:24:31 Seeking Alpha
Traditionally, alcohol and tobacco stocks have performed best out of all sectors. As such, it might make sense to buy an ETF concentrated in these sorts of holdings.
   Global Transdermal Skin Patches Market 2020-2030 - Featuring Profiles of Mylan Pharma, Hisamitsu Pharma, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, and More  2020/06/19 11:30:00 PR Newswire
DUBLIN, June 19, 2020 /PRNewswire/ -- The "Transdermal Skin Patches Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The global transdermal skin patches market was worth $6.23 billion in 2019. It is expected to grow at a compound annual growth rate…

 関連キーワード  (― 米国株 アカシア・リサ―チ ACT AdvisorShares Vice ETF)

 twitter  (公式ツイッターやCEOツイッターなど)